Navigation Links
Par Pharmaceutical Companies Reports Third Quarter 2011 Results
Date:11/2/2011

TSCurrent assets:Cash and cash equivalents$225,969$218,674Available for sale marketable debt securities30,86127,866Accounts receivable, net  98,10395,705Inventories80,98672,580Prepaid expenses and other current assets22,53717,660Deferred income tax assets31,00526,037Income taxes receivable37,86418,605Total current assets527,325477,127Property, plant and equipment, net69,66571,980Intangible assets, net63,42495,467Goodwill63,72963,729Other assets6,4955,441Non-current deferred income tax assets, net55,45169,488Total assets$786,089$783,232LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities:Accounts payable$21,551$23,956Payables due to distribution agreement partners53,47325,310Accrued salaries and employee benefits 11,66016,397Accrued government pricing liabilities39,82432,169Accrued legal fees7,2967,084Accrued legal settlements37,800-Accrued expenses and other current liabilities6,0566,674Total current liabilities177,660111,590Long-term liabilities44,79143,198Commitments and contingencies--Stockholders' equity:Common Stock, par value $0.01 per share, authorized 90,000,000 shares; issued39,662,618 and 38,872,663 shares394389Additional paid-in capital394,468373,764Retained earnings251,140329,129Accumulated other comprehensive (loss) income(21)137Treasury stock, at cost 3,180,643 and 2,970,573 shares(82,343)(74,975)Total stockholders' equity563,638628,444Total liabilities and stockholders' equity$786,089$783,232PAR PHARMACEUTICAL COMPANIES, INC.CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(In Thousands, Except Per Share Data)

(Unaudited)Three months endedNine months endedSeptember 30,September 30,September 30,September 30,2011201020112010Revenues:Net product sales

$208,865$226,131$644,672$763,148Other product related revenues

6,4928,30927,82518,698Total revenues

215,357234,440672,497781,846Cost of goods sold

130,253131,146378,714503,583Gross margin

85,104103,294293,783278,263Operating expenses:Research and development'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) today announced that ... investor conferences.  , 31 st NASDAQ Investor ... 2, 2014 at 6:45 a.m. EST / 11:45 a.m. GMT. ... will provide an overview of the company and a business and ... Conference in New York, NY on Tuesday, ...
(Date:11/26/2014)... 26, 2014 / -- China Nepstar Chain Drugstore Ltd. (NYSE: ... drugstore chain in China based ... the appointment of Ms. Rebecca Yingnan Zhang ... Ms.Zhang has over 20 years of experience ... 1999. Prior to Ms. Zhang,s appointment as the Company,s ...
(Date:11/24/2014)... DIEGO , Nov. 24, 2014  Arena Pharmaceuticals, Inc. ... scheduled to present a corporate overview and update at the ... December 2, 2014, at 8:30 a.m. Eastern Time (5:30 a.m. ... New York . A live audio ... relations section of Arena,s website at www.arenapharm.com . A ...
Breaking Medicine Technology:Jazz Pharmaceuticals Announces Participation in Two Investor Conferences 2China Nepstar Chain Drugstore Appoints Ms. Rebecca Yingnan Zhang as Chief Operating Officer 2China Nepstar Chain Drugstore Appoints Ms. Rebecca Yingnan Zhang as Chief Operating Officer 3Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 3
... -- Tongjitang Chinese Medicines Company ("Tongjitang" or the "Company"; ... of its acquisition by Hanmax Investment Limited, a British ... Limited, a company incorporated in Hong Kong ("Fosun"). As ... wholly owned subsidiary of Hanmax and Fosun. Hanmax is ...
... two-year retrospective cohort study presented at the 63rd Annual ... U.S., showed that patients were significantly more likely to ... chronic ischemic heart diseases after an initial diagnosis of ... "These findings suggest a significant association between a ...
Cached Medicine Technology:Tongjitang Chinese Medicines Company Announces Closing of Merger and Intent to Delist from the NYSE 2Tongjitang Chinese Medicines Company Announces Closing of Merger and Intent to Delist from the NYSE 3New Research Links Restless Legs Syndrome (RLS) to Cardiovascular Disease 2New Research Links Restless Legs Syndrome (RLS) to Cardiovascular Disease 3
(Date:11/26/2014)... Kansas (PRWEB) November 26, 2014 ... will showcase expanded capabilities at RSNA 2014 in ... access, manage and share diagnostic images, photos, videos ... to Perceptive’s booth #8107 will learn more about ... newly acquired technologies and partner initiatives – that ...
(Date:11/26/2014)... who enter puberty early are at increased risk for ... linked with a number of factors associated with depression, ... to the researchers. Early puberty was also linked to ... and having friends who were prone to getting into ... an association between early puberty and these factors, it,s ...
(Date:11/26/2014)... of emergency department visits in the United States rose from ... in 2011, according to the U.S. Centers for Disease Control ... were going to ERs with non-urgent medical needs: 96 percent ... hours of arriving at the ER. In 2010, that number ... of patients arrived at the ER after normal business hours ...
(Date:11/26/2014)... HealthDay Reporter TUESDAY, Nov. 25, 2014 (HealthDay ... disrupt the makeup of bacteria in the digestive system, potentially ... new study suggests. The research doesn,t confirm that ... and study authors aren,t recommending that anyone stop taking the ... used at the lowest dose that provides adequate relief of ...
(Date:11/24/2014)... From embedded sensors and biometrics to elite training ... take center stage at the FitnessTech Summit , presented ... 2015 International CES® , January 6, 2015 in Las Vegas ... The bond between fitness and technology is stronger than ever ... more about the human body. , “Fitness technology has become ...
Breaking Medicine News(10 mins):Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 2Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 3Health News:Early Puberty Linked to Increased Risk of Depression in Teens 2Health News:ER Visits on the Rise, Study Reports 2Health News:Could Popular Heartburn Drugs Upset Your 'Good' Gut Bugs? 2Health News:Could Popular Heartburn Drugs Upset Your 'Good' Gut Bugs? 3Health News:Next Wave Fitness Products Debut at FitnessTech Summit Living in Digital Times at the 2015 International CES 2Health News:Next Wave Fitness Products Debut at FitnessTech Summit Living in Digital Times at the 2015 International CES 3Health News:Next Wave Fitness Products Debut at FitnessTech Summit Living in Digital Times at the 2015 International CES 4
... - Nuvo Research Inc.,(TSX: NRI), a Canadian ... and,development of drug products delivered to and ... drug delivery technologies, and Paladin Labs Inc.,(TSX: ... today,announced modifications to their existing licensing arrangements ...
... Social Security Disability Insurance Should Know Their Income History; Allsup Answers ... ... 8, 2008 -- People who find themselves with a mental or ... the emotional struggle to accept that they no longer can work. ...
... Services® (PPS®), renowned for its award-winning ... an on-demand, interactive case study, Beyond ... for Mid-Face Volumizing, now available on ... explores treatment options for the use ...
... With Only the Best Medical Travel Agencies , ... Vernon Hills, Illinois ... heats up in the U.S., more and more medical tourism agencies (MTAs) ... hospitals should be aware that not all MTAs are created equally. According ...
... Consumer-driven health plans (CDHP) -- hailed since their ... control costs -- are resulting in members forgoing ... problems, according to two newly published studies. , ... out-of-pocket or from a dedicated health-care account before ...
... Research,Center challenged a team of elite climbers to scale ... efforts of researchers to eliminate,cancer as a cause of ... on the Big Expedition for Cancer Research has,recently returned ... the 7,800-foot level of an unclimbed, unnamed peak, as ...
Cached Medicine News:Health News:Nuvo Research and Paladin announce amendments to Pennsaid and Pennsaid Plus agreements 2Health News:Nuvo Research and Paladin announce amendments to Pennsaid and Pennsaid Plus agreements 3Health News:Past Earnings Play Role in Determining SSDI Benefits 2Health News:Past Earnings Play Role in Determining SSDI Benefits 3Health News:Past Earnings Play Role in Determining SSDI Benefits 4Health News:Past Earnings Play Role in Determining SSDI Benefits 5Health News:AestheticEnhance.org Launches CME-Certified Case Study on Mid-Face Volumizing 2Health News:AestheticEnhance.org Launches CME-Certified Case Study on Mid-Face Volumizing 3Health News:An American Appeal to Overseas Hospitals 2Health News:Members of consumer-driven health plans choosing less care 2Health News:Inaugural Big Expedition for Cancer Research Encounters Mountain As Challenging As Finding a Cure for Cancer 2Health News:Inaugural Big Expedition for Cancer Research Encounters Mountain As Challenging As Finding a Cure for Cancer 3Health News:Inaugural Big Expedition for Cancer Research Encounters Mountain As Challenging As Finding a Cure for Cancer 4
The new CR6-45NM non-mydriatic retinal camera is an ideal diagnostic tool for ophthalmologists, optometrists and other medical professionals, especially when it comes to detecting and monitoring diab...
An ideal choice for film photography. The new TRC-50FXC provides 35mm color and Polaroid capability....
Digital imaging for optical screening: Diabetes, glaucoma macular degeneration, and other retinal disease....
All welded construction for strength and durability. Choice of stainless steel or chrome plated models....
Medicine Products: